Clinical Trial Update: Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating cyclophosphamide plus dexamethasone for metastatic castration-resistant prostate cancer; the study is currently listed as a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Rashmi Verma, MD | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING